These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aβ seeds and prions: How close the fit? Rasmussen J; Jucker M; Walker LC Prion; 2017 Jul; 11(4):215-225. PubMed ID: 28657440 [TBL] [Abstract][Full Text] [Related]
3. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Jucker M; Walker LC Ann Neurol; 2011 Oct; 70(4):532-40. PubMed ID: 22028219 [TBL] [Abstract][Full Text] [Related]
4. Alzheimer disease: a tale of two prions. Nussbaum JM; Seward ME; Bloom GS Prion; 2013; 7(1):14-9. PubMed ID: 22965142 [TBL] [Abstract][Full Text] [Related]
5. Prion-like Mechanisms in Alzheimer's Disease. Yin RH; Tan L; Jiang T; Yu JT Curr Alzheimer Res; 2014; 11(8):755-64. PubMed ID: 25212914 [TBL] [Abstract][Full Text] [Related]
6. Prions, prionoids and pathogenic proteins in Alzheimer disease. Ashe KH; Aguzzi A Prion; 2013; 7(1):55-9. PubMed ID: 23208281 [TBL] [Abstract][Full Text] [Related]
7. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. Bloom GS JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463 [TBL] [Abstract][Full Text] [Related]
8. The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease. Walker LC; Schelle J; Jucker M Cold Spring Harb Perspect Med; 2016 Jul; 6(7):. PubMed ID: 27270558 [TBL] [Abstract][Full Text] [Related]
9. Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease. Cohen M; Appleby B; Safar JG Prion; 2016; 10(1):9-17. PubMed ID: 26809345 [TBL] [Abstract][Full Text] [Related]
10. The Exceptional Vulnerability of Humans to Alzheimer's Disease. Walker LC; Jucker M Trends Mol Med; 2017 Jun; 23(6):534-545. PubMed ID: 28483344 [TBL] [Abstract][Full Text] [Related]
11. One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease. Catania M; Di Fede G Prog Mol Biol Transl Sci; 2020; 175():213-237. PubMed ID: 32958234 [TBL] [Abstract][Full Text] [Related]
13. Tau Prion-Like Propagation: State of the Art and Current Challenges. Dujardin S; Hyman BT Adv Exp Med Biol; 2019; 1184():305-325. PubMed ID: 32096046 [TBL] [Abstract][Full Text] [Related]
14. Aβ and tau prions feature in the neuropathogenesis of Down syndrome. Condello C; Maxwell AM; Castillo E; Aoyagi A; Graff C; Ingelsson M; Lannfelt L; Bird TD; Keene CD; Seeley WW; Perl DP; Head E; Prusiner SB Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2212954119. PubMed ID: 36343257 [TBL] [Abstract][Full Text] [Related]
15. A standard model of Alzheimer's disease? Walker LC; Lynn DG; Chernoff YO Prion; 2018; 12(5-6):261-265. PubMed ID: 30220236 [TBL] [Abstract][Full Text] [Related]
16. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease. Tomita T Adv Biol Regul; 2017 May; 64():33-38. PubMed ID: 28082052 [TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation. Hasegawa M Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136595 [TBL] [Abstract][Full Text] [Related]
18. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease. Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531 [TBL] [Abstract][Full Text] [Related]